160 related articles for article (PubMed ID: 33994495)
1. Role of Dipeptidyl Peptidase-4 in Atherosclerotic Cardiovascular Disease in Humans and Animals with Chronic Stress.
Piao L; Li Y; Narisawa M; Shen X; Cheng XW
Int Heart J; 2021 May; 62(3):470-478. PubMed ID: 33994495
[TBL] [Abstract][Full Text] [Related]
2. Dose rectification of an imbalance between DPP4 and GLP-1 ameliorates chronic stress-related vascular aging and atherosclerosis?
Cheng XW; Narisawa M; Jin E; Yu C; Xu W; Piao L
Clin Exp Pharmacol Physiol; 2018 May; 45(5):467-470. PubMed ID: 29220092
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl Peptidase-IV Inhibition for the Treatment of Cardiovascular Disease　- Recent Insights Focusing on Angiogenesis and Neovascularization.
Lei Y; Hu L; Yang G; Piao L; Jin M; Cheng X
Circ J; 2017 May; 81(6):770-776. PubMed ID: 28344207
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease.
Akoumianakis I; Antoniades C
Vascul Pharmacol; 2017 Sep; 96-98():1-4. PubMed ID: 28697993
[TBL] [Abstract][Full Text] [Related]
5. Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.
Piao L; Zhao G; Zhu E; Inoue A; Shibata R; Lei Y; Hu L; Yu C; Yang G; Wu H; Xu W; Okumura K; Ouchi N; Murohara T; Kuzuya M; Cheng XW
J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963101
[TBL] [Abstract][Full Text] [Related]
6. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress.
Lei Y; Yang G; Hu L; Piao L; Inoue A; Jiang H; Sasaki T; Zhao G; Yisireyili M; Yu C; Xu W; Takeshita K; Okumura K; Kuzuya M; Cheng XW;
Int J Cardiol; 2017 Sep; 243():413-420. PubMed ID: 28549747
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).
Thornberry NA; Gallwitz B
Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):479-86. PubMed ID: 19748065
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of DPP-4 inhibition: beyond GLP-1.
Fadini GP; Avogaro A
Vascul Pharmacol; 2011; 55(1-3):10-6. PubMed ID: 21664294
[TBL] [Abstract][Full Text] [Related]
10. Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases.
Xie W; Song X; Liu Z
Vascul Pharmacol; 2018 Oct; 109():17-26. PubMed ID: 29879463
[TBL] [Abstract][Full Text] [Related]
11. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy.
Hasan AA; Hocher B
J Mol Endocrinol; 2017 Jul; 59(1):R1-R10. PubMed ID: 28420715
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibition prevents vascular aging in mice under chronic stress: Modulation of oxidative stress and inflammation.
Xin M; Jin X; Cui X; Jin C; Piao L; Wan Y; Xu S; Zhang S; Yue X; Wang H; Nan Y; Cheng X
Chem Biol Interact; 2019 Dec; 314():108842. PubMed ID: 31586451
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Flatt PR; Bailey CJ; Green BD
Front Biosci; 2008 May; 13():3648-60. PubMed ID: 18508462
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase- IV inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine model.
Yisireyili M; Takeshita K; Hayashi M; Wu H; Uchida Y; Yamamoto K; Kikuchi R; Hao CN; Nakayama T; Cheng XW; Matsushita T; Nakamura S; Murohara T
Psychoneuroendocrinology; 2016 Nov; 73():186-195. PubMed ID: 27509090
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological stimulation of serotonin 5-HT1B receptors enhances increases in plasma active glucagon-like peptide-1 levels induced by dipeptidyl peptidase-4 inhibition independently of feeding in mice.
Nonogaki K; Kaji T
Diabetes Metab; 2015 Nov; 41(5):425-8. PubMed ID: 26234524
[TBL] [Abstract][Full Text] [Related]
16. DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.
Zhang J; Chen Q; Zhong J; Liu C; Zheng B; Gong Q
Front Immunol; 2019; 10():1050. PubMed ID: 31134095
[TBL] [Abstract][Full Text] [Related]
17. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
Salaga M; Mokrowiecka A; Zielinska M; Malecka-Panas E; Kordek R; Kamysz E; Fichna J
J Pharmacol Exp Ther; 2017 Oct; 363(1):92-103. PubMed ID: 28724693
[TBL] [Abstract][Full Text] [Related]
18. Critical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer.
De S; Banerjee S; Kumar SKA; Paira P
Mini Rev Med Chem; 2019; 19(2):88-97. PubMed ID: 29692250
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.
Koska J; Sands M; Burciu C; Reaven P
Diab Vasc Dis Res; 2015 May; 12(3):154-63. PubMed ID: 25852133
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
